{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:19:23Z","timestamp":1783203563537,"version":"3.54.6"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,6]],"date-time":"2014-10-06T00:00:00Z","timestamp":1412553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Lundbeck LLC"},{"name":"Robert A Vaughan Family Fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jns.2014.09.053","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T02:55:23Z","timestamp":1412823323000},"page":"219-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease"],"prefix":"10.1016","volume":"347","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-8069","authenticated-orcid":false,"given":"Deb A.","family":"Kegelmeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne D.","family":"Kloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora E.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne M.","family":"Fiumedora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra K.","family":"Kostyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jns.2014.09.053_bb0005","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/mds.22003","article-title":"Falls and gait disturbances in Huntington's disease","volume":"23","author":"Grimbergen","year":"2008","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.jns.2014.09.053_bb0010","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1212\/WNL.35.10.1450","article-title":"The gait abnormality of Huntington's disease","volume":"35","author":"Koller","year":"1985","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2014.09.053_bb0015","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/jnnp.47.8.848","article-title":"Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease","volume":"47","author":"Girotti","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2014.09.053_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004850-200203000-00009","article-title":"High-dose olanzapine in Huntington's disease","volume":"17","author":"Bonelli","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.jns.2014.09.053_bb0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hup.474","article-title":"Zotepine in Huntington's disease","volume":"18","author":"Bonelli","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.jns.2014.09.053_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2377-9-62","article-title":"Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group\/TETRA-HD Investigators","volume":"9","author":"Frank","year":"2009","journal-title":"BMC Neurol"},{"issue":"5","key":"10.1016\/j.jns.2014.09.053_bb0035","first-page":"1","article-title":"Effect of tetrabenazine on motor function in patients with Huntington disease","volume":"1","author":"Ferrara","year":"2012","journal-title":"Neurol Ther"},{"key":"10.1016\/j.jns.2014.09.053_bb0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5334\/tohm.91","article-title":"Clinical assessment of the effect of tetrabenazine on functional scales in Huntington disease: a pilot open label study","author":"Fekete","year":"2012","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"5","key":"10.1016\/j.jns.2014.09.053_bb0045","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/mds.23606","article-title":"Coordination of fingertip forces during precision grip in premanifest Huntington's disease","volume":"26","author":"Rao","year":"2011","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.jns.2014.09.053_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency","volume":"11","author":"Huntington's Study Group","year":"1996","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.jns.2014.09.053_bb0055","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/mds.20482","article-title":"Reliability of spatiotemporal gait outcome measures in Huntington's disease","volume":"20","author":"Rao","year":"2005","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.jns.2014.09.053_bb0060","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1002\/mds.23421","article-title":"Fall risk assessment using the Tinetti Mobility Test in individuals with Huntington's disease","volume":"25","author":"Kloos","year":"2010","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.jns.2014.09.053_bb0065","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2522\/ptj.20130032","article-title":"Reliability and minimal detectable change of physical performance measures in individuals with pre-manifest and manifest Huntington disease","volume":"93","author":"Quinn","year":"2013","journal-title":"Phys Ther"},{"issue":"10","key":"10.1016\/j.jns.2014.09.053_bb0070","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ptj\/85.10.1034","article-title":"Clinical measurement of sit-to-stand performance in people with balance disorders: validity of data for the Five-Times-Sit-to-Stand Test","volume":"85","author":"Whitney","year":"2005","journal-title":"Phys Ther"},{"issue":"2","key":"10.1016\/j.jns.2014.09.053_bb0075","first-page":"169","article-title":"Romberg's test","volume":"49","author":"Khasnis","year":"2003","journal-title":"J Postgrad Med"},{"issue":"1","key":"10.1016\/j.jns.2014.09.053_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mds.21161","article-title":"Short-term effects of tetrabenazine on chorea associated with Huntington's disease","volume":"22","author":"Kenney","year":"2007","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jns.2014.09.053_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410110108","article-title":"Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study","volume":"11","author":"Jankovic","year":"1982","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jns.2014.09.053_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0166-4328(94)00154-8","article-title":"Kinetics: our window into the goals and strategies of the central nervous system","volume":"67","author":"Winter","year":"1995","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.jns.2014.09.053_bb0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.gaitpost.2010.01.018","article-title":"Medio-lateral stability of sit-to-walk performance in older individuals with and without fear of falling","volume":"31","author":"Aberg","year":"2010","journal-title":"Gait Posture"},{"issue":"2","key":"10.1016\/j.jns.2014.09.053_bb0100","doi-asserted-by":"crossref","first-page":"e30903","DOI":"10.1371\/journal.pone.0030903","article-title":"The impact of different types of assistive devices on gait measures and safety in Huntington's disease","volume":"7","author":"Kloos","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jns.2014.09.053_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jht.2011.05.001","article-title":"Assessing dexterity function: a comparison of two alternatives for the NIH Toolbox","volume":"24","author":"Wang","year":"2011","journal-title":"J Hand Ther"},{"issue":"16","key":"10.1016\/j.jns.2014.09.053_bb0110","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/mds.23300","article-title":"Grasping premanifest Huntington's disease\u2014shaping new endpoints for new trials","volume":"25","author":"Reilmann","year":"2010","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.jns.2014.09.053_bb0115","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1345\/aph.1M582","article-title":"Role of tetrabenazine for Huntington's disease-associated chorea","volume":"44","author":"Poon","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.jns.2014.09.053_bb0120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.wnf.0000136892.24629.96","article-title":"Tetrabenazine treatment in movement disorders","volume":"27","author":"Paleacu","year":"2004","journal-title":"Clin Neuropharmacol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14006534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14006534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:43:42Z","timestamp":1758383022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14006534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0022510X14006534"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.09.053","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.09.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}